BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28353282)

  • 1. LRRK2 and the Immune System.
    Dzamko NL
    Adv Neurobiol; 2017; 14():123-143. PubMed ID: 28353282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 as a target for modulating immune system responses.
    Russo I; Bubacco L; Greggio E
    Neurobiol Dis; 2022 Jul; 169():105724. PubMed ID: 35427743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 regulation of immune-pathways and inflammatory disease.
    Wallings RL; Tansey MG
    Biochem Soc Trans; 2019 Dec; 47(6):1581-1595. PubMed ID: 31769472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.
    Lee H; James WS; Cowley SA
    Biochem Soc Trans; 2017 Feb; 45(1):131-139. PubMed ID: 28202666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond.
    Bae JR; Lee BD
    BMB Rep; 2015 May; 48(5):243-8. PubMed ID: 25703537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
    Monfrini E; Di Fonzo A
    Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 in Infection: Friend or Foe?
    Herbst S; Gutierrez MG
    ACS Infect Dis; 2019 Jun; 5(6):809-815. PubMed ID: 30915830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14
    Ikezu T; Koro L; Wolozin B; Farraye FA; Strongosky AJ; Wszolek ZK
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):794-800. PubMed ID: 32180132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson disease-associated
    Park J; Lee JW; Cooper SC; Broxmeyer HE; Cannon JR; Kim CH
    J Leukoc Biol; 2017 Oct; 102(4):1093-1102. PubMed ID: 28751472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An emerging role for LRRK2 in the immune system.
    Dzamko N; Halliday GM
    Biochem Soc Trans; 2012 Oct; 40(5):1134-9. PubMed ID: 22988878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
    Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
    Elife; 2020 Feb; 9():. PubMed ID: 32057291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
    Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
    Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
    Dzamko N; Rowe DB; Halliday GM
    Mov Disord; 2016 Jun; 31(6):889-97. PubMed ID: 26917005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of LRRK2-Associated Parkinson's Disease.
    Xiong Y; Dawson TM; Dawson VL
    Adv Neurobiol; 2017; 14():163-191. PubMed ID: 28353284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
    Yan R; Liu Z
    Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich repeat kinase 2 at a glance.
    Zhu C; Herbst S; Lewis PA
    J Cell Sci; 2023 Sep; 136(17):. PubMed ID: 37698513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.
    Rideout HJ; Stefanis L
    Neurochem Res; 2014; 39(3):576-92. PubMed ID: 23729298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.
    Hakimi M; Selvanantham T; Swinton E; Padmore RF; Tong Y; Kabbach G; Venderova K; Girardin SE; Bulman DE; Scherzer CR; LaVoie MJ; Gris D; Park DS; Angel JB; Shen J; Philpott DJ; Schlossmacher MG
    J Neural Transm (Vienna); 2011 May; 118(5):795-808. PubMed ID: 21552986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases.
    Tsafaras G; Baekelandt V
    Neurobiol Dis; 2022 Oct; 172():105806. PubMed ID: 35781002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.